Insider Selling: Movano (NASDAQ:MOVE) CFO Sells 8,218 Shares of Stock

Movano Inc. (NASDAQ:MOVE) CFO Jeremy Cogan sold 8,218 shares of the firm’s stock in a transaction dated Tuesday, January 6th. The stock was sold at an average price of $7.79, for a total value of $64,018.22. Following the completion of the transaction, the chief financial officer owned 15,107 shares of the company’s stock, valued at approximately $117,683.53. This represents a 35.23% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Jeremy Cogan also recently made the following trade(s):

• On Monday, January 5th, Jeremy Cogan sold 1,879 shares of Movano stock. The stock was sold at an average price of $8.35, for a total transaction of $15,689.65.

Movano Stock Down 6.9%

NASDAQ:MOVE traded down $0.52 during mid-day trading on Monday, hitting $6.97. 24,936 shares of the stock traded hands, compared to its average volume of 32,819. The business’s 50-day moving average price is $8.79 and its 200 day moving average price is $7.57. The company has a market cap of $5.82 million, a PE ratio of -0.64 and a beta of 0.79. Movano Inc. has a 12-month low of $4.67 and a 12-month high of $58.76.

Movano (NASDAQ:MOVE) last posted its earnings results on Friday, November 14th. The technology company reported ($4.73) earnings per share (EPS) for the quarter, topping the consensus estimate of ($7.00) by $2.27. The business had revenue of $0.08 million for the quarter, compared to analysts’ expectations of $3.88 million. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%.

Institutional Trading of Movano

A hedge fund recently bought a new stake in Movano stock. Citadel Advisors LLC bought a new position in Movano Inc. (NASDAQ:MOVE) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned about 5.94% of Movano as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 16.64% of the company’s stock.

Trending Headlines about Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Short interest fell in December: as of Dec. 31 short interest dropped to 43,438 shares (‑29.1% vs Dec. 15). That represented roughly 5.8% of shares sold short and a days-to-cover of about 0.5, which reduces immediate squeeze risk and can be viewed as a short‑term positive for the stock.
• Neutral Sentiment: January short-interest report flagged a “significant increase” as of Jan. 12 but the published figures show 0 shares and an NaN change — an internal data/reporting inconsistency. Investors should treat this as unresolved data; a confirmed rise in short interest would be bearish, but the current entry looks like a reporting error and warrants watching for corrected filings.
• Negative Sentiment: Underlying fundamentals remain weak: most recent quarterly results showed a smaller-than-expected EPS loss but revenue was essentially negligible relative to estimates and the company reported extreme negative margins and return on equity. Those results underscore continued cash-burn and revenue execution risk for this very small‑cap company.
• Negative Sentiment: Low market cap and thin liquidity amplify moves: Movano’s market capitalization and average volume are small, so headline-driven flows (shorting, data corrections, or small trades) can produce outsized price swings. That structural risk likely contributes to the downward pressure today.

Wall Street Analyst Weigh In

MOVE has been the subject of several recent analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Movano in a report on Wednesday, October 8th. Wall Street Zen raised shares of Movano to a “hold” rating in a research note on Saturday, December 20th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Movano currently has an average rating of “Sell”.

Movano Company Profile

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.